Deep learning-enabled multiplexed point-of-care sensor using a paper-based fluorescence vertical flow assay
AI-generated Key Points
⚠The license of the paper does not allow us to build upon its content and the key points are generated using the paper metadata rather than the full article.
- The paper presents a novel point-of-care serodiagnosis assay that can simultaneously quantify three biomarkers of acute cardiac injury.
- The assay employs a paper-based fluorescence vertical flow platform (fxVFA) that is processed by a low-cost mobile reader and trained neural networks to quantify the target biomarkers within less than 15 minutes of test time, using only 50 microliters of serum sample per patient.
- The fxVFA platform was validated using human serum samples to quantify three cardiac biomarkers: myoglobin, creatine kinase-MB (CK-MB), and heart-type fatty acid binding protein (FABP).
- The platform achieved less than 0.52 ng/mL limit-of-detection for all three biomarkers with minimal cross-reactivity.
- The concentration quantification of the biomarkers was tested using 46 individually activated cartridges which showed high correlation with the ground truth concentrations for all three biomarkers achieving more than 0.9 linearity and less than 15% coefficient of variation.
- This multiplexed computational fxVFA has competitive performance along with its inexpensive paper-based design and handheld footprint, making it an effective point-of-care sensor platform that could expand access to diagnostics in resource limited settings.
- This technology can be used for early detection and management of acute cardiac injuries which is essential in improving patient outcomes.
Authors: Artem Goncharov, Hyou-Arm Joung, Rajesh Ghosh, Gyeo-Re Han, Zachary S. Ballard, Quinn Maloney, Alexandra Bell, Chew Tin Zar Aung, Omai B. Garner, Dino Di Carlo, Aydogan Ozcan
Abstract: We demonstrate multiplexed computational sensing with a point-of-care serodiagnosis assay to simultaneously quantify three biomarkers of acute cardiac injury. This point-of-care sensor includes a paper-based fluorescence vertical flow assay (fxVFA) processed by a low-cost mobile reader, which quantifies the target biomarkers through trained neural networks, all within <15 min of test time using 50 microliters of serum sample per patient. This fxVFA platform is validated using human serum samples to quantify three cardiac biomarkers, i.e., myoglobin, creatine kinase-MB (CK-MB) and heart-type fatty acid binding protein (FABP), achieving less than 0.52 ng/mL limit-of-detection for all three biomarkers with minimal cross-reactivity. Biomarker concentration quantification using the fxVFA that is coupled to neural network-based inference is blindly tested using 46 individually activated cartridges, which showed a high correlation with the ground truth concentrations for all three biomarkers achieving > 0.9 linearity and < 15 % coefficient of variation. The competitive performance of this multiplexed computational fxVFA along with its inexpensive paper-based design and handheld footprint make it a promising point-of-care sensor platform that could expand access to diagnostics in resource-limited settings.
Ask questions about this paper to our AI assistant
You can also chat with multiple papers at once here.
⚠The license of the paper does not allow us to build upon its content and the AI assistant only knows about the paper metadata rather than the full article.
Welcome to our AI assistant! Here are some important things to keep in mind:
- The assistant will only answer questions related to this specific paper.
- Please note that this is not a bot for casual chatting.
- If you want the answer in a language other than the language you chose for navigating the website, simply add "TRANSLATE IN LANGUAGE L" at the end of your query (replace "LANGUAGE L" with the language of your choice).
- For example, you could ask "Can you extract the most important aspect of the paper? TRANSLATE IN SPANISH".
- If you want to keep the history of your questions/answers you should create an account.
Assess the quality of the AI-generated content by voting
Why do we need votes?
Votes are used to determine whether we need to re-run our summarizing tools. If the count reaches -10, our tools can be restarted.
Similar papers summarized with our AI tools
Navigate through even more similar papers through atree representation
Look for similar papers (in beta version)
By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.
Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.